Join
Live feed
·
INSIDERFilingvia Quantisnow
Takeda Pharmaceutical Company Limited logo

Chief Financial Officer Furuta Milano was granted 12,300 units of Ordinary Shares, increasing direct ownership by 21% to 70,200 units (SEC Form 4) (tax withholding)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track TAK (Takeda Pharmaceutical Company Limited) and more on Quantisnow.